Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 4 , Pages 189-198 , April 2010

Fatty acids and signalling in endothelial cells

References 

  1. Schwartz SM. Role of endothelial integrity in atherosclerosis. Artery. 1980;8:305–314
  2. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics—2009 update: a report from the American Heart association statistics committee and stroke statistics subcommittee. Circulation. 2009;119:e21–e181
  3. Psota TL, Gebauer SK, Kris-Etherton P. Dietary omega-3 fatty acid intake and cardiovascular risk. Am. J. Cardiol. 2006;98:3i–18i
  4. Willett WC, Stampfer MJ, Manson JE, et al. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet. 1993;341:581–585
  5. Pietinen P, Ascherio A, Korhonen P, et al. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am. J. Epidemiol. 1997;145:876–887
  6. Oomen CM, Ocke MC, Feskens EJ, van Erp-Barrt MJ, Kok FJ, Kromhout D. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet. 2001;357:746–751
  7. Doran AC, Meller N, McNamara CA. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arteriosclerosis Thromb. Vasc. Biol. 2008;28:812–819
  8. Cines DB, Pollak ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 1998;91:3527–3561
  9. Giannotti G, Landmesser U. Endothelial dysfunction as an early sign of atherosclerosis. Herz. 2007;32:568–572
  10. Pearson JD. Normal endothelial cell function. Lupus. 2000;9:183–188
  11. Förstermann U, Mügge A, Bode SM, Frölich JC. Response of human coronary arteries to aggregating platelets: importance of endothelium-derived relaxing factor and prostanoids. Circ. Res. 1988;63:306–312
  12. Otsuji S, Nakajima O, Waku S, et al. Attenuation of acetylcholine-induced vasoconstriction by l-arginine is related to the progression of atherosclerosis. Am. Heart J. 1995;129:1094–1100
  13. Rao RM, Yang L, Garcia-Cardena G, Luscinskas FW. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circ. Res. 2007;101:234–247
  14. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868–874
  15. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005;352:1685–1695
  16. Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflammation Res. 2000;49:497–505
  17. Duval C, Chinetti G, Trottein F, Fruchart JC, Staels B. The role of PPARs in atherosclerosis. Trends Mol. Med. 2002;8:422–430
  18. Marx N, Duez H, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ. Res. 2004;94:1168–1178
  19. Wang P, Anderson PO, Chen S, Paulsson KM, Sjögren HO, Li S. Inhibition of the transcription factors AP-1 and NF-κB in CD4 T cells by peroxisome proliferator-activated receptor γ ligands. Int. Immunopharmacol. 2001;1:803–812
  20. Göttlicher M, Widmark E, Li Q, Gustafsson JA. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA. 1992;89:4653–4657
  21. Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and γ. Proc. Natl. Acad. Sci. USA. 1997;94:4312–4317
  22. Kliewer SA, Lenhard JM, Wilson TM, Patel I, Morris DC, Lehmann JM. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor and promotes adipocyte differentiation. Cell. 1995;83:803–812
  23. Krey G, Braissant O, L'Horset F, et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 1997;11:779–791
  24. Ringseis R, Eder K. Influence of conjugated linoleic acids on functional properties of vascular cells. Br. J. Nutr. 2009;22:1–18
  25. Wan YJ, An D, Cai Y, et al. Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver. Mol. Cell. Biol. 2000;20:4436–4444
  26. Germain P, Chambon P, Eichele G, et al. International Union of Pharmacology. LXIII. Retinoid X receptors. Pharmacol. Rev. 2006;58:760–772
  27. Heyman RA, Mangelsdorf DJ, Dyck JA, et al. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell. 1992;68:397–406
  28. De Urquiza AM, Liu S, Sjoberg M, et al. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science. 2000;290:2140–2144
  29. Lengqvist J, Mata De Urquiza A, Bergman AC, et al. Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor α ligand-binding domain. Mol. Cell. Proteomics. 2004;3:692–703
  30. Fan YY, Spencer TE, Wang N, Moyer MP, Chapkin RS. Chemopreventive n-3 fatty acids activate RXRα in colonocytes. Carcinogenesis. 2003;24:1541–1548
  31. Lampen A, Meyer S, Nau H. Phytanic acid and docosahexaenoic acid increase the metabolism of all-trans-retinoic acid and CYP26 gene expression in intestinal cells. Biochim. Biophys. Acta. 2001;1521:97–106
  32. Lemotte PK, Keidel S, Apfel CM. Phytanic acid is a retinoid X receptor ligand. Eur. J. Biochem. 1996;236:328–333
  33. Claudel T, Leibowitz MD, Fievet C, et al. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. Proc. Natl. Acad. Sci. USA. 2001;98:2610–2615
  34. Lalloyer F, Fiévet C, Lestavel S, et al. The RXR agonist bexarotene improves cholesterol homeostasis and inhibits atherosclerosis progression in a mouse model of mixed dyslipidemia. Arteriosclerosis Thromb. Vasc. Biol. 2006;26:2731–2737
  35. Chai D, Wang B, Shen L, Pu J, Zhang XK, He B. RXR agonists inhibit high-glucose-induced oxidative stress by repressing PKC activity in human endothelial cells. Free Radical Biol. Med. 2008;44:1334–1347
  36. De Martin R, Hoeth M, Hofer-Warbinek R, Schmid JA. The transcription factor NF-κB and the regulation of vascular cell function. Arteriosclerosis Thromb. Vasc. Biol. 2000;20:E83–E88
  37. Jones WK, Brown M, Wilhide M, He S, Ren X. NF-κB in cardiovascular disease: diverse and specific effects of a “general” transcription factor?. Cardiovasc. Toxicol. 2005;5:183–202
  38. Hennig B, Toborek M, Joshi-Barve S, et al. Linoleic acid activates nuclear transcription factor-kappa B (NF-κB) and induces NF-κB-dependent transcription in cultured endothelial cells. Am. J. Clin. Nutr. 1996;63:322–328
  39. Toborek M, Barger SW, Mattson MP, Barve S, McClain CJ, Hennig B. Linoleic acid and TNF-α cross-amplify oxidative injury and dysfunction of endothelial cells. J. Lipid Res. 1996;37:123–135
  40. Hennig B, Meerarani P, Ramadass P, Watkins BA, Toborek M. Fatty acid-mediated activation of vascular endothelial cells. Metabolism. 2000;49:1006–1013
  41. Park HJ, Lee YW, Hennig B, Toborek M. Linoleic acid-induced VCAM-1 expression in human microvascular endothelial cells is mediated by the NF-kappa B-dependent pathway. Nutr. Cancer. 2001;41:126–134
  42. Dichtl W, Ares MP, Jönson AN, et al. Linoleic acid-stimulated vascular adhesion molecule-1 expression in endothelial cells depends on nuclear factor-κB activation. Metabolism. 2002;51:327–333
  43. Toborek M, Lee YW, Garrido R, Kaiser S, Hennig B. Unsaturated fatty acids selectively induce an inflammatory environment in human endothelial cells. Am. J. Clin. Nutr. 2002;75:119–125
  44. Reiterer G, Toborek M, Hennig B. Quercetin protects against linoleic acid-induced porcine endothelial cell dysfunction. J. Nutr. 2004;134:771–775
  45. Saraswathi V, Wu G, Toborek M, Hennig B. Linoleic acid-induced endothelial activation: role of calcium and peroxynitrite signaling. J. Lipid Res. 2004;45:794–804
  46. Hennig B, Lei W, Arzuaga X, Ghosh DD, Saraswathi V, Toborek M. Linoleic acid induces proinflammatory events in vascular endothelial cells via activation of PI3K/Akt and ERK1/2 signaling. J. Nutr. Biochem. 2006;17:766–772
  47. Wang L, Lim EJ, Toborek M, Hennig B. The role of fatty acids and caveolin-1 in tumor necrosis factor alpha-induced endothelial cell activation. Metabolism. 2008;57:1328–1339
  48. Zheng Y, Lim EJ, Wang L, Smart EJ, Toborek M, Hennig B. Role of caveolin-1 in EGCG-mediated protection against linoleic-acid-induced endothelial cell activation. J. Nutr. Biochem. 2009;20:202–209
  49. Sizemore N, Leung S, Stark GR. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol. Cell. Biol. 1999;19:4798–4805
  50. Madrid LV, Mayo MW, Reuther JY, Baldwin AS. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 2001;276:18934–18940
  51. Huang ZH, Bates EJ, Ferrante JV, et al. Inhibition of stimulus-induced endothelial cell intercellular adhesion molecule-1, E-selectin, and vascular cellular adhesion molecule-1 expression by arachidonic acid and its hydroxy and hydroperoxy derivatives. Circ. Res. 1997;80:149–158
  52. Stuhlmeier KM, Kao JJ, Bach FH. Arachidonic acid influences proinflammatory gene induction by stabilizing the inhibitor-kappaBalpha/nuclear factor-kappaB (NF-kappaB) complex, thus suppressing the nuclear translocation of NF-kappaB. J. Biol. Chem. 1997;272:24679–24683
  53. Ciapaite J, van Bezu J, van Eikenhorst G, et al. Palmitate and oleate have distinct effects on the inflammatory phenotype of human endothelial cells. Biochim. Biophys. Acta. 2007;1771:147–154
  54. Weber C, Erl W, Pietsch A, Danesch U, Weber PC. Docosahexaenoic acid selectively attenuates induction of vascular cell adhesion molecule-1 and subsequent monocytic cell adhesion to human endothelial cells stimulated by tumor necrosis factor-α. Arteriosclerosis Thromb. Vasc. Biol. 1995;15:622–628
  55. Chen W, Esselman WJ, Jump DB, Busik JV. Anti-inflammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cells. Invest. Ophthalmol. Visual Sci. 2005;46:4342–4347
  56. Goua M, Mulgrew S, Frank J, Rees D, Sneddon AA, Wahle KW. Regulation of adhesion molecule expression in human endothelial and smooth muscle cells by omega-3 fatty acids and conjugated linoleic acids: involvement of the transcription factor NF-κB?. Prostaglandins Leukotrienes Essent. Fatty Acids. 2008;78:33–43
  57. Xue H, Wan M, Song D, Li Y, Li J. Eicosapentaenoic acid and docosahexaenoic acid modulate mitogen-activated protein kinase activity in endothelium. Vasc. Pharmacol. 2006;44:434–439
  58. Carluccio MA, Massaro M, Bonfrate C, et al. Oleic acid inhibits endothelial activation: a direct vascular antiatherogenic mechanism of a nutritional component in the mediterranean diet. Arteriosclerosis Thromb. Vasc. Biol. 1999;19:220–228
  59. Schleser S, Ringseis R, Eder K. Conjugated linoleic acids have no effect on TNFα-induced adhesion molecule expression, U937 monocyte adhesion, and chemokine release in human aortic endothelial cells. Atherosclerosis. 2006;186:337–344
  60. Sneddon AA, McLeod E, Wahle KW, Arthur JR. Cytokine-induced monocyte adhesion to endothelial cells involves platelet-activating factor: suppression by conjugated linoleic acid. Biochim. Biophys. Acta. 2006;1761:793–801
  61. Spector AA, Hoak JC, Fry GL, Denning GM, Stoll LL, Smith JB. Effect of fatty acid modification on prostacyclin production by cultured human endothelial cells. J. Clin. Invest. 1980;65:1003–1012
  62. Endresen MJ, Tøsti E, Heimli H, Lorentzen B, Henriksen T. Effects of free fatty acids found increased in women who develop pre-eclampsia on the ability of endothelial cells to produce prostacyclin, cGMP and inhibit platelet aggregation. Scand. J. Clin. Lab. Invest. 1994;54:549–557
  63. Spector AA, Yorek MA. Membrane lipid composition and cellular function. J. Lipid Res. 1985;26:1015–1035
  64. Vossen RC, van Dam-Mieras MC, Lemmens PJ, Hornstra G, Zwaal RF. Membrane fatty acid composition and endothelial cell functional properties. Biochim. Biophys. Acta. 1991;1083:243–251
  65. Couloubaly S, Deloménie C, Rousseau D, Paul JL, Grynberg A, Pourci ML. Fatty acid incorporation in endothelial cells and effects on endothelial nitric oxide synthase. Eur. J. Clin. Invest. 2007;37:692–699
  66. Davda RK, Stepniakowski KT, Lu G, Ullian ME, Goodfriend TL, Egan BM. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension. 1995;26:764–770
  67. Moers A, Schrezenmeir J. Palmitic acid but not stearic acid inhibits NO-production in endothelial cells. Exp. Clin. Endocrinol. Diabetes. 1997;105S:78–80
  68. Zhu W, Smart EJ. Myristic acid stimulates endothelial nitric-oxide synthase in a CD36- and an AMP kinase-dependent manner. J. Biol. Chem. 2005;280:29543–29550
  69. Kuroda R, Hirata K, Kawashima S, Yokoyama M. Unsaturated free fatty acids inhibit Ca2+ mobilization and NO release in endothelial cells. Kobe J. Med. Sci. 2001;47:211–219
  70. Artwohl M, Roden M, Waldhäusl W, Freudenthaler A, Baumgartner-Parzer SM. Free fatty acids trigger apoptosis and inhibit cell cycle progression in human vascular endothelial cells. FASEB J. 2004;18:146–158
  71. Achard F, Gilbert M, Bénistant C, et al. Eicosapentaenoic and docosahexaenoic acids reduce PGH synthase 1 expression in bovine aortic endothelial cells. Biochem. Biophys. Res. Commun. 1997;241:513–518
  72. Murakami K, Chan SY, Routtenberg A. Protein kinase C activation by cis-fatty acid in the absence of Ca2+ and phospholipids. J. Biol. Chem. 1986;261:15424–15429
  73. Lu G, Morinelli TA, Meier KE, Rosenzweig SA, Egan BM. Oleic acid induced mitogenic signalling in human aortic smooth muscle cells: a role for protein kinase C. J. Invest. Med. 1995;43:375
  74. Herrera MD, Pérez-Guerrero C, Marhuenda E, Ruiz-Gutiérrez V. Effects of dietary oleic-rich oils (virgin olive and high-oleic-acid sunflower) on vascular reactivity in Wistar-Kyoto and spontaneously hypertensive rats. Br. J. Nutr. 2001;86:349–357
  75. Chisaki K, Okuda Y, Suzuki S, et al. Eicosapentaenoic acid suppresses basal and insulin-stimulated endothelin-1 production in human endothelial cells. Hypertension Res. 2003;26:655–661
  76. Park JY, Kim YM, Song HS, et al. Oleic acid induces endothelin-1 expression through activation of protein kinase C and NF-κB. Biochem. Biophys. Res. Commun. 2003;303:891–895
  77. Spector AA, Kaduce TL, Hoak JC, Fry GL. Utilization of arachidonic and linoleic acids by cultured human endothelial cells. J. Clin. Invest. 1981;68:1003–1011
  78. Garcia MC, Sprecher H, Rosenthal MD. Chain elongation of polyunsaturated fatty acids by vascular endothelial cells: studies with arachidonate analogues. Lipids. 1990;25:211–215
  79. Marcus AJ, Weksler BB, Jaffe EA. Enzymatic conversion of prostaglandin endoperoxide H2 and arachidonic acid to prostacyclin by cultured human endothelial cells. J. Biol. Chem. 1978;253:7138–7141
  80. Nordøy A, Svensson B, Hoak JC. The effects of albumin bound fatty acids on the platelet inhibitory function of human endothelial cells. Eur. J. Clin. Invest. 1979;9:5–10
  81. Cosentino F, Lüscher TF. Tetrahydrobiopterin and endothelial nitric oxide synthase activity. Cardiovasc. Res. 1999;43:274–278
  82. Tardivel S, Gousset-Dupont A, Robert V, Pourci ML, Grynberg A, Lacour B. Protective effects of EPA and deleterious effects of DHA on eNOS activity in Ea hy 926 cultured with lysophosphatidylcholine. Lipids. 2009;44:225–235
  83. Jamin SP, Crabos M, Catheline M, Martin-Chouly C, Legrand AB, Saïag B. Eicosapentaenoic acid reduces thrombin-evoked release of endothelin-1 in cultured bovine endothelial cells. Res. Commun. Mol. Pathol. Pharmacol. 1999;105:271–281
  84. Hadjiagapiou C, Kaduce TL, Spector AA. Eicosapentaenoic acid utilization by bovine aortic endothelial cells: effects on prostacyclin production. Biochim. Biophys. Acta. 1986;875:369–381
  85. Lands WE, Byrnes MJ. The influence of ambient peroxides on the conversion of 5,8,11,14,17—eicosapentaenoic acid to prostaglandins. Prog. Lipid Res. 1981;20:287–290
  86. Spector AA, Kaduce TL, Figard PH, Norton KC, Hoak JC, Czervionke RL. Eicosapentaenoic acid and prostacyclin production by cultured human endothelial cells. J. Lipid Res. 1983;24:1595–1604
  87. Serhan CN, Hong S, Gronert K, et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 2002;196:1025–1037
  88. Schwab JM, Chiang N, Arita M, Serhan CN. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature. 2007;447:869–874
  89. Okuda Y, Kawashima K, Sawada T, et al. Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells. Biochem. Biophys. Res. Commun. 1997;232:487–491
  90. Omura M, Kobayashi S, Mizukami Y, et al. Eicosapentaenoic acid (EPA) induces Ca(2+)-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation. FEBS Lett. 487. 2001;pp. 361–366
  91. Li Q, Zhang Q, Wang M, et al. Docosahexaenoic acid affects endothelial nitric oxide synthase in caveolae. Arch. Biochem. Biophys. 2007;466:250–259
  92. Moncada S, Higgs EA. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur. J. Clin. Invest. 1991;21:361–374
  93. Shimokawa H, Aarhus LL, Vanhoutte PM. Dietary omega 3 polyunsaturated fatty acids augment endothelium-dependent relaxation to bradykinin in coronary microvessels of the pig. Br. J. Pharmacol. 1988;95:1191–1196
  94. Lockette WE, Webb RC, Culp BR, Pitt B. Vascular reactivity and high dietary eicosapentaenoic acid. Prostaglandins. 1982;24:631–639
  95. Minshall RD, Sessa WC, Stan RV, Anderson RG, Malik AB. Caveolin regulation of endothelial function. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003;285:L1179–L1183
  96. Lin S, Fagan KA, Li KX, Shaul PW, Cooper DM, Rodman DM. Sustained endothelial nitric-oxide synthase activation requires capacitative Ca2+ entry. J. Biol. Chem. 2000;275:17979–17985
  97. Shaul PW, Smart EJ, Robinson LJ, et al. Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J. Biol. Chem. 1996;271:6518–6522
  98. Li Q, Zhang Q, Wang M, et al. Eicosapentaenoic acid modifies lipid composition in caveolae and induces translocation of endothelial nitric oxide synthase. Biochimie. 2007;89:169–177
  99. Lee TH, Hoover RL, Williams JD, et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N. Engl. J. Med. 1985;312:1217–1224
  100. Stebbins CL, Stice JP, Hart CM, Mbai FN, Knowlton AA. Effects of dietary decosahexaenoic acid (DHA) on eNOS in human coronary artery endothelial cells. J. Cardiovasc. Pharmacol. Ther. 2008;13:261–268
  101. Coen P, Cummins P, Birney Y, Devery R, Cahill P. Modulation of nitric oxide and 6-keto-prostaglandin F(1α) production in bovine aortic endothelial cells by conjugated linoleic acid. Endothelium. 2004;11:211–220
  102. Eder K, Schleser S, Becker K, Körting R. Conjugated linoleic acids lower the release of eicosanoids and nitric oxide from human aortic endothelial cells. J. Nutr. 2003;133:4083–4089
  103. Torres-Duarte AP, Vanderhoek JY. Conjugated linoleic acid exhibits stimulatory and inhibitory effects on prostanoid production in human endothelial cells and platelets. Biochim. Biophys. Acta. 2003;1640:69–76
  104. Urquhart P, Parkin SM, Rogers JS, Bosley JA, Nicolaou A. The effect of conjugated linoleic acid on arachidonic acid metabolism and eicosanoid production in human saphenous vein endothelial cells. Biochim. Biophys. Acta. 2002;1580:150–160
  105. Eder K, Slomma N, Becker K. Trans-10,cis-12 conjugated linoleic acid suppresses the desaturation of linoleic and α-linolenic acids in HepG2 cells. J. Nutr. 2002;132:1115–1121
  106. Stachowska E, Dziedziejko V, Safranow K, et al. Inhibition of phospholipase A2 activity by conjugated linoleic acids in human macrophages. Eur. J. Nutr. 2007;46:28–33
  107. Nugteren DH, Christ-Hazelhof E. Naturally occurring conjugated octadecatrienoic acids are strong inhibitors of prostaglandin biosynthesis. Prostaglandins. 1987;33:403–417
  108. Bulgarella JA, Patton D, Bull AW. Modulation of prostaglandin H synthase activity by conjugated linoleic acid (CLA) and specific CLA isomers. Lipids. 2001;36:407–412
  109. Ringseis R, Müller A, Herter C, Gahler S, Steinhart H, Eder K. CLA isomers inhibit TNFα-induced eicosanoid release from human vascular smooth muscle cells a PPARγ ligand-like action. Biochim. Biophys. Acta. 2006;1760:290–300
  110. Jenko KJ, Vanderhoek JY. Conjugated linoleic acids and CLA-containing phospholipids inhibit NO formation in aortic endothelial cells. Lipids. 2008;43:335–342
  111. Dancu MB, Berardi DE, Vanden Heuvel JP, Tarbell JM. Atherogenic endothelial cell eNOS and ET-1 Responses to asynchronous hemodynamics are mitigated by conjugated linoleic acid. Ann. Biomed. Eng. 2007;35:1111–1119
  112. Satoh H, Tsukamoto K, Hashimoto Y, et al. Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARγ on vascular endothelial function. Biochem. Biophys. Res. Commun. 1999;254:757–763
  113. Degner SC, Kemp MQ, Bowden GT, Romagnolo DF. Conjugated linoleic acid attenuates cyclooxygenase-2 transcriptional activity via an anti-AP-1 mechanism in MCF-7 breast cancer cells. J. Nutr. 2006;136:421–427
  114. Lopez-Garcia E, Schulze MB, Meigs JB. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J. Nutr. 2005;135:562–566
  115. Baer DJ, Judd JT, Clevidence BA, Tracy RP. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am. J. Clin. Nutr. 2004;79:969–973
  116. De Roos NM, Bots ML, Katan MB. Replacement of dietary saturated fatty acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arteriosclerosis Thromb. Vasc. Biol. 2001;21:1233–1237
  117. De Roos NM, Siebelink E, Bots ML, van Tol A, Schouten EG, Katan MB. Trans monounsaturated fatty acids and saturated fatty acids have similar effects on postprandial flow-mediated vasodilation. Eur. J. Clin. Nutr. 2002;56:674–679
  118. Kummerow FA, Mahfouz MM, Zhou Q. Trans fatty acids in partially hydrogenated soybean oil inhibit prostacyclin release by endothelial cells in presence of high level of linoleic acid. Prostaglandins Other Lipid Mediators. 2007;84:138–153
  119. Loï C, Chardigny JM, Cordelet C, et al. Incorporation and metabolism of trans 20:5 in endothelial cells. Effect on prostacyclin synthesis. Lipids. 2000;35:911–918
  120. Shaw DI, Hall WL, Jeffs NR, Williams CM. Comparative effects of fatty acids on endothelial inflammatory gene expression. Eur. J. Nutr. 2007;46:321–328
  121. Holthe MR, Andersson Y, Lyberg T. Lack of proinflammatory effects of free fatty acids on human umbilical cord vein endothelial cells and leukocytes. Acta Obstet. Gynecol. Scand. 2005;84:672–678
  122. De Caterina R, Bernini W, Carluccio MA, Liao JK, Libby P. Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids. J. Lipid Res. 1998;39:1062–1070
  123. Reissig D, Rassoul F, Salvetter J, Wagner O, Richter V. Effect of fatty acids on expression of endothelial leukocyte adhesion molecules. Eur. J. Nutr. 2003;42:224–227
  124. Massaro M, Carluccio MA, Paolicchi A, Bosetti F, Solaini G, De Caterina R. Mechanisms for reduction of endothelial activation by oleate: inhibition of nuclear factor-kappaB through antioxidant effects. Prostaglandins Leukotrienes Essent. Fatty Acids. 2002;67:175–181
  125. De Caterina R, Libby P. Control of endothelial leukocyte adhesion molecules by fatty acids. Lipids. 1996;31S:S57–S63
  126. Collie-Duguid ES, Wahle KW. Inhibitory effect of fish oil n-3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules. Biochem. Biophys. Res. Commun. 1996;220:969–974
  127. De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA, Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arteriosclerosis Thromb. 1994;14:1829–1836
  128. De Caterina R, Massaro M. Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes. J. Membr. Biol. 2005;206:103–116
  129. Yamada H, Yoshida M, Nakano Y, et al. In vivo and in vitro inhibition of monocyte adhesion to endothelial cells and endothelial adhesion molecules by eicosapentaenoic acid. Arteriosclerosis Thromb. Vasc. Biol. 2008;28:2173–2179
  130. Sanderson P, Calder PC. Dietary fish oil diminishes lymphocyte adhesion to macrophage and endothelial cell monolayers. Immunology. 1998;94:79–87
  131. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J. 1995;9:899–909
  132. Calder PC. Polyunsaturated fatty acids and inflammation. Prostaglandins Leukotrienes Essent. Fatty Acids. 2006;75:197–202
  133. Miles EA, Thies F, Wallace FA, et al. Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations. Clin. Sci. (London). 2001;100:91–100
  134. Kalogeropoulou K, Mortzos G, Migdalis I, et al. Carotid atherosclerosis in type 2 diabetes mellitus: potential role of endothelin-1, lipoperoxides, and prostacyclin. Angiology. 2002;53:279–285

PII: S0952-3278(10)00066-9

doi: 10.1016/j.plefa.2010.02.022

Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 4 , Pages 189-198 , April 2010

Article Tools

* Image Usage & Resolution